Plunkett Research Online: Acorda Therapeutics Inc

ACORDA THERAPEUTICS INC (ACOR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Acorda Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SPI) and other disorders of the central nervo.....



Acorda Therapeutics Inc
Ticker: ACOR
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 914-347-4300
Fax: 914-347-4560
Address: 420 Saw Mill River Road
Ardsley, NY 10502 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
Ron CohenCEO/Director/Founder/President
David LawrenceChief Accounting Officer/Other Executive Officer
See More
Acorda Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SPI) and other disorders of the central nervo.....See More See More

Auditor: Ernst &Young, LLP
Legal Advisor: Covington & Burling LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Ampyra
Inbrija
SYN120
BTT1023
rHIgM22
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: